German researchers have recently discovered that a drug for the treatment of hematological tumors can be used to treat anti-NMDA receptor encephalitis and to treat critically ill patients effectively.
Anti-NMDA receptor encephalitis, which is an anti-N-methyl-D-aspartate receptor encephalitis, is an autoimmune disease that causes schizophrenia, epilepsy, dyskinesia and other symptoms due to brain inflammation. Lead to death of the patient. In recent years, this type of encephalitis, which is mostly caused by women, has received the attention of the medical community.
Researchers at the Shalithai University Hospital in Berlin and the German Center for Neurodegenerative Diseases found that existing standard therapies have limited efficacy in patients with severe encephalitis, and five critically ill patients were tested after adding the drug bortezomib to the standard therapy. Symptoms improve rapidly. Bortezomib is a proteasome inhibitor originally used to treat rare blood tumors, plasmacytoma.
RT-PCR Test Reagent Kit Of COVID-19(ORF1ab, N)
The RT-PCR Test Reagent Kit Of COVID-19(ORF1ab, N) is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19 by their healthcare provider.
Results are for the identification of SARS-CoV-2 RNA.The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection.
Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infective status. The agent detected may not be the definite cause of disease. Positive results do not rule out bacterial co-infection with other viruses.
Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The COVID-19 RT-PCR Detection Kit is intended for use by qualified trained clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.
RT-PCR testing reagent kit,RT PCR test reagent,Covid-19 PCR Diagnostic reagent,RT PCR reagent kit,real time PCR test reagent
Shenzhen Uni-medica Technology Co.,Ltd , https://www.unimedicadevice.com